Page last updated: 2024-09-05

erlotinib hydrochloride and Acneiform Eruptions

erlotinib hydrochloride has been researched along with Acneiform Eruptions in 22 studies

Research

Studies (22)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	11 (50.00)	29.6817
2010's	11 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Hsu, WH; Loong, HH; Mok, TS; Yang, JC	1
Asano, M; Boku, N; Fujiwara, Y; Higashiyama, A; Inoue, A; Inoue, Y; Kanda, S; Kikuchi, K; Mizutani, H; Mori, T; Nakai, Y; Nozawa, K; Ohe, Y; Taguchi, O; Takahashi, M; Takashima, A; Yamazaki, N	1
Kao, S; Mahendran, A; Sebaratnam, DF; Wong, XL	1
Megahed, M; Wahl, RU	1
Kishi, A; Kiyohara, Y; Yamazaki, N	1
Chiu, HC; Chiu, HY	1
Funazaki, H; Ichida, Y; Ikeda, M; Kobayashi, M; Mitsunaga, S; Ohno, I; Okusaka, T; Okuyama, H; Saitoh, S; Shimizu, S; Shinohara, A; Takahashi, H; Takahashi, K	1
Chen, KL; Cho, YT; Chu, CY; Lin, CC; Sheen, YS; Tsai, HE; Yang, CW	1
Bianchi, F; Neri, I; Patrizi, A	1
Brown, CW; Campbell, TM	1
Barletta, E; Cusano, F; Ferrara, G; Ingordo, V	1
Alkemade, JA; Bovenschen, HJ	1
Dirschka, T; Hauschild, A; Kroth, J; Wollenberg, A	1
Domínguez-Fernández, I; Eguren, C; García-Díez, A; Santiago-Sánchez-Mateos, DI	1
Llombart, B; Requena, C; Sanmartín, O	1
Journagan, S; Obadiah, J	1
Acebo, E; Díaz-Pérez, JL; Lasa, O; Martínez de Lagrán, Z; Ratón, JA	1
Sipples, R	1
Basti, S; Jampol, LM; Zhang, G	1
Nguyen, D; Parr, AL; Steinberg, SM; Tan, AR; Yang, SX	1
Schalock, PC; Zug, KA	1
Cruz Hernández, JJ; Delgado Fernández, C; Mezquita Pérez, L; Navarro Martín, M; Rodríguez Sánchez, C	1

Reviews

4 review(s) available for erlotinib hydrochloride and Acneiform Eruptions

Article	Year
Overview of current systemic management of EGFR-mutant NSCLC. Annals of oncology : official journal of the European Society for Medical Oncology, 2018, 01-01, Volume: 29, Issue:suppl_1 Topics: Acneiform Eruptions; Antineoplastic Combined Chemotherapy Protocols; Bevacizumab; Carcinoma, Non-Small-Cell Lung; Chemical and Drug Induced Liver Injury; Diarrhea; Drug Resistance, Neoplasm; ErbB Receptors; Erlotinib Hydrochloride; Exons; Humans; Lung Diseases, Interstitial; Lung Neoplasms; Molecular Targeted Therapy; Mucositis; Paronychia; Patient Selection; Progression-Free Survival; Protein Kinase Inhibitors; Randomized Controlled Trials as Topic	2018
Erlotinib-related skin toxicities: treatment strategies in patients with metastatic non-small cell lung cancer. Journal of the American Academy of Dermatology, 2013, Volume: 69, Issue:3 Topics: Acneiform Eruptions; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Eruptions; Erlotinib Hydrochloride; Humans; Ichthyosis; Lung Neoplasms; Paronychia; Patient Education as Topic; Pruritus; Quinazolines	2013
[Cutaneous side effects of EGFR inhibitors--appearance and management]. Deutsche medizinische Wochenschrift (1946), 2010, Volume: 135, Issue:4 Topics: Acneiform Eruptions; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Hair Diseases; Humans; Ichthyosis; Mucositis; Neoplasms; Panitumumab; Paronychia; Protein Kinase Inhibitors; Quinazolines	2010
Common side effects of anti-EGFR therapy: acneform rash. Seminars in oncology nursing, 2006, Volume: 22, Issue:1 Suppl 1 Topics: Acneiform Eruptions; Anti-Bacterial Agents; Anti-Inflammatory Agents; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; Diarrhea; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Humans; Neoplasms; Nurse's Role; Oncology Nursing; Patient Education as Topic; Quinazolines; Severity of Illness Index	2006

Trials

1 trial(s) available for erlotinib hydrochloride and Acneiform Eruptions

Article	Year
Markers in the epidermal growth factor receptor pathway and skin toxicity during erlotinib treatment. Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:1 Topics: Acneiform Eruptions; Antineoplastic Agents; Biomarkers; Biopsy; Breast Neoplasms; Carcinoma; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Folliculitis; Gene Expression Profiling; Humans; Ki-67 Antigen; Mitogen-Activated Protein Kinases; Neoplasm Proteins; Phosphorylation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; Skin	2008

Article

Year

Markers in the epidermal growth factor receptor pathway and skin toxicity during erlotinib treatment.

Annals of oncology : official journal of the European Society for Medical Oncology, 2008, Volume: 19, Issue:1

Topics: Acneiform Eruptions; Antineoplastic Agents; Biomarkers; Biopsy; Breast Neoplasms; Carcinoma; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Folliculitis; Gene Expression Profiling; Humans; Ki-67 Antigen; Mitogen-Activated Protein Kinases; Neoplasm Proteins; Phosphorylation; Protein Kinase Inhibitors; Protein Processing, Post-Translational; Proto-Oncogene Proteins c-akt; Quinazolines; Signal Transduction; Skin

2008

Other Studies

17 other study(ies) available for erlotinib hydrochloride and Acneiform Eruptions

Article	Year
Instrumental evaluation sensitively detects subclinical skin changes by the epidermal growth factor receptor inhibitors and risk factors for severe acneiform eruption. The Journal of dermatology, 2019, Volume: 46, Issue:1 Topics: Acneiform Eruptions; Adult; Afatinib; Aged; Antineoplastic Agents; Cetuximab; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Male; Middle Aged; Neoplasms; Prognosis; Risk Factors; Skin; Water Loss, Insensible	2019
Treatment of erlotinib-induced acneiform eruption with chromophore gel-assisted phototherapy. Photodermatology, photoimmunology & photomedicine, 2019, Volume: 35, Issue:3 Topics: Acneiform Eruptions; Administration, Topical; Benzoyl Peroxide; Drug Eruptions; Erlotinib Hydrochloride; Female; Humans; Methylprednisolone; Middle Aged; Phototherapy	2019
[Erlotinib-induced acneiform eruption]. Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete, 2013, Volume: 64, Issue:5 Topics: Acneiform Eruptions; Adenocarcinoma; Aged; Anti-Bacterial Agents; Anti-Inflammatory Agents; Ciprofloxacin; Doxycycline; Drug Therapy, Combination; Erlotinib Hydrochloride; Fluoroquinolones; Humans; Lung Neoplasms; Male; Methylprednisolone; Quinazolines; Quinolizines; Treatment Outcome	2013
Scalp pustules in a patient receiving chemotherapy. JAMA, 2013, Sep-11, Volume: 310, Issue:10 Topics: Acneiform Eruptions; Aged; Aged, 80 and over; Biopsy; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Gefitinib; Humans; Lung Neoplasms; Male; Quinazolines; Scalp	2013
Efficacy of prophylactic minocycline treatment for skin toxicities induced by erlotinib plus gemcitabine in patients with advanced pancreatic cancer: a retrospective study. American journal of clinical dermatology, 2015, Volume: 16, Issue:3 Topics: Acneiform Eruptions; Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Dermatologic Agents; Drug Eruptions; Erlotinib Hydrochloride; Female; Gemcitabine; Humans; Male; Middle Aged; Minocycline; Pancreatic Neoplasms; Retrospective Studies	2015
Comparison of Skin Toxic Effects Associated With Gefitinib, Erlotinib, or Afatinib Treatment for Non-Small Cell Lung Cancer. JAMA dermatology, 2016, Volume: 152, Issue:3 Topics: Acneiform Eruptions; Afatinib; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Non-Small-Cell Lung; Cohort Studies; Compassionate Use Trials; Cross-Sectional Studies; Drug Eruptions; Erlotinib Hydrochloride; Gefitinib; Humans; Ichthyosis; Lung Neoplasms; Paronychia; Pruritus; Quinazolines; Retrospective Studies	2016
Rosaceiform eruption induced by erlotinib. Dermatologic therapy, 2008, Volume: 21 Suppl 2 Topics: Acneiform Eruptions; Aged, 80 and over; Carcinoma, Non-Small-Cell Lung; Drug Eruptions; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Male; Protein Kinase Inhibitors; Quinazolines	2008
Dimorphic cutaneous manifestation of a toxic eruption due to erlotinib therapy. Journal of drugs in dermatology : JDD, 2008, Volume: 7, Issue:12 Topics: Acneiform Eruptions; Aged; Drug Eruptions; Erlotinib Hydrochloride; Folliculitis; Humans; Male; Protein Kinase Inhibitors; Psoriasis; Quinazolines	2008
Erlotinib-induced pustular eruption. Giornale italiano di dermatologia e venereologia : organo ufficiale, Societa italiana di dermatologia e sifilografia, 2009, Volume: 144, Issue:1 Topics: Acneiform Eruptions; Administration, Cutaneous; Anti-Bacterial Agents; Carcinoma, Non-Small-Cell Lung; Erlotinib Hydrochloride; Erythromycin; Gels; Humans; Lung Neoplasms; Male; Middle Aged; Protein Kinase Inhibitors; Quinazolines; Treatment Outcome	2009
Erlotinib-induced dermatologic side-effects. International journal of dermatology, 2009, Volume: 48, Issue:3 Topics: Acneiform Eruptions; Aged; Antineoplastic Agents; Chickenpox; Drug Eruptions; Epidermal Growth Factor; Erlotinib Hydrochloride; Female; Herpesvirus 3, Human; Humans; Protein Kinase Inhibitors; Quinazolines; Virus Activation	2009
[Erlotinib-induced acneiform rash not affecting previously irradiated skin]. Actas dermo-sifiliograficas, 2010, Volume: 101, Issue:2 Topics: Acneiform Eruptions; Antineoplastic Agents; Arm; Carcinoma, Squamous Cell; Combined Modality Therapy; ErbB Receptors; Erlotinib Hydrochloride; Facial Dermatoses; Humans; Laryngeal Neoplasms; Laryngectomy; Male; Middle Aged; Neck Dissection; Neoplasm Proteins; Organ Specificity; Protein Kinase Inhibitors; Quinazolines; Radiotherapy, Adjuvant; Skin; Thorax	2010
Acneiform eruptions induced by epidermal growth factor receptor inhibitors: treatment with oral isotretinoin. Cutis, 2012, Volume: 90, Issue:2 Topics: Acneiform Eruptions; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antineoplastic Agents; Cetuximab; Dermatologic Agents; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Isotretinoin; Male; Quinazolines	2012
An acneiform eruption due to erlotinib: prognostic implications and management. Journal of the American Academy of Dermatology, 2006, Volume: 54, Issue:2 Topics: Acneiform Eruptions; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Erlotinib Hydrochloride; Female; Humans; Lung Neoplasms; Middle Aged; Prognosis; Quinazolines	2006
[Acneiform eruption from epidermal growth factor receptor inhibitors]. Actas dermo-sifiliograficas, 2005, Volume: 96, Issue:7 Topics: Acneiform Eruptions; Aged; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Cetuximab; Drug Eruptions; ErbB Receptors; Erlotinib Hydrochloride; Female; Gefitinib; Humans; Male; Middle Aged; Quinazolines	2005
Acquired trichomegaly and symptomatic external ocular changes in patients receiving epidermal growth factor receptor inhibitors: case reports and a review of literature. Cornea, 2007, Volume: 26, Issue:7 Topics: Acneiform Eruptions; Adenocarcinoma, Bronchiolo-Alveolar; Aged, 80 and over; Antineoplastic Agents; Blepharitis; Carcinoma, Small Cell; ErbB Receptors; Erlotinib Hydrochloride; Eyelashes; Female; Gefitinib; Humans; Hypertrichosis; Lung Neoplasms; Middle Aged; Quinazolines; Retrospective Studies	2007
Acneiform reaction to erlotinib. Dermatitis : contact, atopic, occupational, drug, 2007, Volume: 18, Issue:4 Topics: Acneiform Eruptions; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Drug Eruptions; Erlotinib Hydrochloride; Humans; Lung Neoplasms; Male; Middle Aged; Protein Kinase Inhibitors; Quinazolines	2007
[Acneiforme rash in woman with pulmonary adenocarcinoma]. Revista clinica espanola, 2008, Volume: 208, Issue:5 Topics: Acneiform Eruptions; Adenocarcinoma; Aged; Drug Eruptions; Erlotinib Hydrochloride; Facial Dermatoses; Female; Humans; Lung Neoplasms; Protein Kinase Inhibitors; Quinazolines	2008